about
The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phaseProtein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive LeukemiasA mouse model of pulmonary metastasis from spontaneous osteosarcoma monitored in vivo by Luciferase imaging.Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.Conditional activation of MET in differentiated skeletal muscle induces atrophy.Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance.SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes.Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environmentsThe muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiationPML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity.Amplification failure of the amelogenin gene (AMELX) caused by a primer binding site mutation.Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in RhabdomyosarcomaUnleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia.Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis.A genetic platform to model sarcomagenesis from primary adult mesenchymal stem cells.The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive LeukemiasMechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 ComplexFailure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma.The oncogenic transcription factor PAX3-FKHR can convert fibroblasts into contractile myotubes.Leptin enhances STAT-3 phosphorylation in HC11 cell line: effect on cell differentiation and cell viability.NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line.The targetable role of herpes virus-associated ubiquitin-specific protease (HAUSP) in p190 BCR-ABL leukemia.RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesis.15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins.Tumor suppressors revival in CLLTherapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones.Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion.High levels of Cre expression in neuronal progenitors cause defects in brain development leading to microencephaly and hydrocephaly.Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells."Snorkeling" for missing players in cancer.Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leukemia cells.Differential expression of microRNA-206 in skeletal muscle of female Piedmontese and Friesian cattle.Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment.Inhibition of bromodomain and extra-terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemia
P50
Q26749343-313B62D8-B406-41B7-846C-DAAD66B0F727Q26769590-24053AC2-1218-47C6-A1C2-BBB4601547FDQ33324404-7409E7BD-CF39-435F-A573-2C5FCE983E6CQ33677421-6D050D0C-FBD2-42DC-96F3-B247F697CB1FQ34595811-C7F4CA6B-CA9A-4DAD-8180-F51078BD1ACAQ35234477-EAFEB7EF-E6D0-49CF-BB09-C63F6408415EQ36186504-27A585F8-7E7B-4BCF-808C-0C76AC4F180FQ36739725-FCACF292-D389-4D7E-918A-BA85055563F2Q36820041-68B2E762-409B-44C0-9D7D-5F21BC9DAC20Q37286651-286D35A7-A6C4-4C80-B2BA-51A67FD7C00AQ37686992-4FA38C26-86B7-4BA9-8767-320B43B327CBQ38349520-DAD90E6B-B3D6-495C-B5DE-17E6818FBC77Q38749559-1207C261-B9CB-4867-B4AC-5AE15C8977B8Q38862637-353AA725-D74B-4215-ACC5-E58ED071E204Q38912800-8D7BDC5D-1EB1-472B-8F43-261F96361537Q38917207-2F85865A-AE98-4636-B32C-38B58BDB4E18Q38937733-1818B281-1711-4A57-9955-B83058B57872Q39029101-29390C99-25C2-49E8-9F54-4BBE8DCD456BQ39144774-01067334-4092-4AD3-9C2C-C110770AE401Q40134893-BAA80837-73FD-491E-87EF-66CCCEECDAD1Q40214620-CDB811B7-91F8-402F-848C-E6E1A71B1486Q40234154-C53E72DC-4A7C-4122-81C1-759273B99D4FQ40450173-7466EDAA-452B-4F96-8313-0A4581484619Q40456936-BF5BBD06-714B-40C0-AC55-EC2EA7C2630CQ40501213-A0F32073-7978-4C9A-BFA7-9995D5295D17Q41008451-08FAC3B2-E2D8-4135-9FB9-3C9C1CE54A9DQ41056246-F02AFA2C-D799-4D56-BA29-67F36868B930Q41547633-F269F8ED-5FF8-4119-9724-2AAA1667BD0BQ41919230-40540B25-2F25-4A3E-B552-F1B2B06ED1EBQ42026501-C11E1FBF-AFC3-4D66-9623-4C1D7D126A06Q42248531-12D919D6-64A7-4EFC-A81F-246BB3AECF91Q42802665-7588F821-8FEE-4388-AD0B-A1B51F7F6D55Q46917660-687C19D1-47DB-4DC2-BB73-C45B33EE790FQ51508324-789CA4FD-FFDD-467C-95F7-54EF28D8236DQ52688134-64651E9C-954E-47F7-B5FE-F347E87DD6B3Q91845925-84A19EBD-9514-43EB-912E-AB12100EE1AE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Riccardo Taulli
@ast
Riccardo Taulli
@en
Riccardo Taulli
@es
Riccardo Taulli
@nl
type
label
Riccardo Taulli
@ast
Riccardo Taulli
@en
Riccardo Taulli
@es
Riccardo Taulli
@nl
prefLabel
Riccardo Taulli
@ast
Riccardo Taulli
@en
Riccardo Taulli
@es
Riccardo Taulli
@nl
P106
P1153
8351211100
P31
P496
0000-0003-1277-6263